UM  > 中華醫藥研究院
Analysis of Pogostemon cablin from pharmaceutical research to market performances
Chen MW1; Zhang JM1; Lai YF1; Wang SP1; Li P1; Xiao J2; Fu CM3; Hu H1; Wang YT1
Source PublicationExpert Opinion on Investigational Drugs

Introduction: Pogostemon cablin (P. cablin), called Ciruicao or Guanghuoxiang, is a well-known Chinese materia medica in southeast Asia that is widely used in gastrointestinal disease and exterior syndromes, being confirmed by both in vitro and in vivo studies. To exploit this traditional medicine that adequately fits modern drugs, however, a comprehensive review about its pharmacy research and market performance is extremely necessary.

Areas covered: This article reviews various components extracted from this plant as well as the biological activities derived from those chemical compositions. The authors summarize the quality evaluation and highlight the therapeutic effects of P. cablin, such as antiviral activities, antioxidation effect, antiinflammatory, analgesic activities, and intestinal barrier function protection. The preparation profile of P. cablin and some future related research were also described in this review. Last but not least, a market performance analysis was conducted.

Expert opinion: P. cablin has beneficial therapeutic potential as an effective adaptogenic herbal remedy in clinic. Molecular mechanisms and active targets of P. cablin compounds, the qualitative and quantitative standard of P. cablin, as well as novel drug delivery systems of P. cablin, would be developed.

KeywordChemical Composition Market Performances Pharmacological Effect Pogostemon Cablin Quality Evaluation
Indexed BySCI
WOS Research AreaPharmacology & Pharmacy
WOS SubjectPharmacology & Pharmacy
WOS IDWOS:000313592000007
Fulltext Access
Citation statistics
Cited Times [WOS]:17   [WOS Record]     [Related Records in WOS]
Document TypeJournal article
CollectionInstitute of Chinese Medical Sciences
Affiliation1.University of Macau, Institute of Chinese Medical Sciences, State Key Laboratory of Quality Research in Chinese Medicine, Av. Padre Tomas Pereira S.J., Taipa, Macao, China.
2.Cixi Hospital, School of Pharmacy, Wenzhou Medical College, Wenzhou, China
3.Chengdu University of Traditional Chinese Medicine, Pharmacy College, Chengdu, China
First Author AffilicationInstitute of Chinese Medical Sciences
Recommended Citation
GB/T 7714
Chen MW,Zhang JM,Lai YF,et al. Analysis of Pogostemon cablin from pharmaceutical research to market performances[J]. Expert Opinion on Investigational Drugs,2013,22(2):245-257.
APA Chen MW.,Zhang JM.,Lai YF.,Wang SP.,Li P.,...&Wang YT.(2013).Analysis of Pogostemon cablin from pharmaceutical research to market performances.Expert Opinion on Investigational Drugs,22(2),245-257.
MLA Chen MW,et al."Analysis of Pogostemon cablin from pharmaceutical research to market performances".Expert Opinion on Investigational Drugs 22.2(2013):245-257.
Related Services
Recommend this item
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Chen MW]'s Articles
[Zhang JM]'s Articles
[Lai YF]'s Articles
Baidu academic
Similar articles in Baidu academic
[Chen MW]'s Articles
[Zhang JM]'s Articles
[Lai YF]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Chen MW]'s Articles
[Zhang JM]'s Articles
[Lai YF]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.